A systematic review of the effectiveness and cost-effectiveness of palivizumab (SynagisR) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection

Susan Simpson; Amanda Burls

A systematic review of the effectiveness and cost-effectiveness of palivizumab (SynagisR) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection

Susan Simpson
, Amanda Burls

Research output: Book/Report › Commissioned report

Original language	English
Publisher	Department of Public Health and Epidemiology, University of Birmingham
ISBN (Print)	0704423219
Publication status	Published - 1 Jan 2001

Cite this

@book{4236adf6be294fb792e9ca87da94705b,

title = "A systematic review of the effectiveness and cost-effectiveness of palivizumab (SynagisR) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection",

author = "Susan Simpson and Amanda Burls",

year = "2001",

month = jan,

day = "1",

language = "English",

isbn = "0704423219",

publisher = "Department of Public Health and Epidemiology, University of Birmingham",

}

TY - BOOK

T1 - A systematic review of the effectiveness and cost-effectiveness of palivizumab (SynagisR) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection

AU - Simpson, Susan

AU - Burls, Amanda

PY - 2001/1/1

Y1 - 2001/1/1

M3 - Commissioned report

SN - 0704423219

BT - A systematic review of the effectiveness and cost-effectiveness of palivizumab (SynagisR) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection

PB - Department of Public Health and Epidemiology, University of Birmingham

ER -